We have shown that choline phosphate or phosphorylcholine (ChoP) is found on the surface of numerous bacterial species. In particular, many of the major pathogens that colonize the mucosal surface of the respiratory tract, including members of the genera Streptococcus, Haemophilus, Neisseda and Actinobacillus, express this otherwise unusual prokaryotic structure. We have relied on comparisons of isogenic ChoP+ and ChoP- mutants of H. influenzae to define the contribution of bacterial ChoP to colonization and the pathogenesis of disease. Where possible we have extended our findings to the leading pathogen, S. pneumoniae. Bacterial expression of ChoP allows for mimicry of host phospholipids. For each of the above genera, choline is obtained exclusively from host sources. Since choline is also a nutritional requirement for host cells, choline depletion by bacteria may be a previously unrecognized source of cytopathic effect.
Specific Aim One will examine the effect of competition for choline on host cells. Progress during the previous funding period showed that bacterial ChoP reduces susceptibility to antimicrobial peptides that target differences between host and microbial membranes. Moreover, bacterial ChoP mimicry of platelet-activating factor (PAF) allows for attachment to epithelial cells through binding to its receptor, rPAF. Since PAF is a mediator of inflammation and cell-signaling events, interaction with rPAF could render host clearance mechanisms more permissive for bacterial survival. Such an effect could explain why multiple species utilize this common receptor.
Specific Aim Two will determine the effect of bacterial adherence via ChoP on this receptor and rPAF-mediated signaling events. The expression of ChoP is highly variable suggesting that in some circumstances its expression is disadvantageous for bacterial survival. We have shown that ChoP is the target of both innate (C-reactive protein, which is present on the airway surface) and adaptive (human ChoP-specific IgG2) immune responses. The effectiveness of antibody to ChoP suggests that ChoP could serve as a common target antigen for protection against respiratory tract pathogens.
Specific Aim Three will determine the effects of the immune response to ChoP on colonization, since there is a selection for ChoP-expressing bacteria during carriage, including natural human carriage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
2R21AI044231-06
Application #
6827131
Study Section
Special Emphasis Panel (ZRG1-IDM-A (02))
Program Officer
Klein, David L
Project Start
1999-08-01
Project End
2005-05-31
Budget Start
2004-08-15
Budget End
2005-05-31
Support Year
6
Fiscal Year
2004
Total Cost
$349,675
Indirect Cost
Name
University of Pennsylvania
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Langereis, Jeroen D; Weiser, Jeffrey N (2014) Shielding of a lipooligosaccharide IgM epitope allows evasion of neutrophil-mediated killing of an invasive strain of nontypeable Haemophilus influenzae. MBio 5:e01478-14
Langereis, Jeroen D; de Jonge, Marien I; Weiser, Jeffrey N (2014) Binding of human factor H to outer membrane protein P5 of non-typeable Haemophilus influenzae contributes to complement resistance. Mol Microbiol 94:89-106
Clark, Sarah E; Snow, Julian; Li, Jianjun et al. (2012) Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae. PLoS Pathog 8:e1002521
Clarke, Thomas B; Francella, Nicholas; Huegel, Alyssa et al. (2011) Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe 9:404-14
Nakamura, Shigeki; Davis, Kimberly M; Weiser, Jeffrey N (2011) Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest 121:3657-65
Davis, Kimberly M; Weiser, Jeffrey N (2011) Modifications to the peptidoglycan backbone help bacteria to establish infection. Infect Immun 79:562-70
Nakamura, Shigeki; Shchepetov, Mikhail; Dalia, Ankur B et al. (2011) Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae. PLoS Pathog 7:e1001247
Dalia, Ankur B; Weiser, Jeffrey N (2011) Minimization of bacterial size allows for complement evasion and is overcome by the agglutinating effect of antibody. Cell Host Microbe 10:486-96
Davis, Kimberly M; Nakamura, Shigeki; Weiser, Jeffrey N (2011) Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest 121:3666-76
Weiser, Jeffrey N (2010) The pneumococcus: why a commensal misbehaves. J Mol Med (Berl) 88:97-102

Showing the most recent 10 out of 19 publications